Cargando…
Role of APOE and Age at Enrollment in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
BACKGROUND: The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) tested whether non-steroidal anti-inflammatory drugs (NSAIDs) can prevent Alzheimer's disease (AD). The results were null. We analyzed ADAPT data to examine if the effects of NSAIDs on AD risk differed depending...
Autores principales: | Drye, Lea T., Zandi, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435528/ https://www.ncbi.nlm.nih.gov/pubmed/22962554 http://dx.doi.org/10.1159/000341783 |
Ejemplares similares
-
Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Publicado: (2006) -
Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer’s disease
por: Patrick, Rhonda P.
Publicado: (2019) -
Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013) -
The Role of Upregulated APOE in Alzheimer’s Disease Etiology
por: Gottschalk, William K, et al.
Publicado: (2016) -
APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease
por: Yassine, Hussein N., et al.
Publicado: (2020)